On May 22, 2018, Stryker Orthopedics updated its LFIT V40 Femoral Head Recall to include eight (8) additional catalog numbers. The original recall occurred in August 2016 and included seven (7) catalog numbers which represented close to 45,000 devices in commerce. The LFIT V40 is a femoral head that is utilized in hip replacement surgeries. According to the recall, Stryker has received a higher than expected number of femoral head/hip stem dissociations. Severe complications from the LFIT V40 Head include:
- Pain associated with implant loosening
- Peri-prosthetic fracture
- Revision to alleviate a hazardous situation
- Leg length discrepancy
- Loss of mobility secondary to hip/stem trunnion fracture or femoral head/hip stem dissociation
- Pain requiring revision surgery
- Inflammatory response
- Adverse local tissue reaction (ALTR)
The Stryker LFIT V40 is designed to offer a broad range of offsets based on the patients needs and can be used interchangeably with Stryker’s entire product line of modular total hip arthroplasty devices. Unfortunately, due to the potential corrosion at the head-neck junction, catastrophic dissociation and metallosis can occur and require emergent revision surgery.
The Unsafe Drug and Medical Device Team at Plymale Law are investigating the Stryker LFIT CoCr V40 femoral head cases on behalf of patients who were implanted with these devices and have suffered complications. In the event you receive any calls regarding these products, we welcome the opportunity to work with you and your clients.